| Typicality: | 0.459 |
| Saliency: | 0.491 |
| in people with hiv | 4 | location |
| antibody → target → pd-1 | 27 |
| antibody → be directed against → pd-1 | 5 |
| antibody → target → the pd-1 pathway | 3 |
| antibody → block → the pd-1 pathway | 3 |
| negative | neutral | positive |
| 0.063 | 0.564 | 0.373 |
| Raw frequency | 38 |
| Normalized frequency | 0.491 |
| Modifier score | 0.500 |
| Perplexity | 57.163 |